Ramalingam, A.; Mustafa, N.; Chng, W.J.; Medimagh, M.; Sambandam, S.; Issaoui, N.
3-Chloro-3-methyl-2,6-diarylpiperidin-4-ones as Anti-Cancer Agents: Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADMET Prediction. Biomolecules 2022, 12, 1093.
https://doi.org/10.3390/biom12081093
AMA Style
Ramalingam A, Mustafa N, Chng WJ, Medimagh M, Sambandam S, Issaoui N.
3-Chloro-3-methyl-2,6-diarylpiperidin-4-ones as Anti-Cancer Agents: Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADMET Prediction. Biomolecules. 2022; 12(8):1093.
https://doi.org/10.3390/biom12081093
Chicago/Turabian Style
Ramalingam, Arulraj, Nurulhuda Mustafa, Wee Joo Chng, Mouna Medimagh, Sivakumar Sambandam, and Noureddine Issaoui.
2022. "3-Chloro-3-methyl-2,6-diarylpiperidin-4-ones as Anti-Cancer Agents: Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADMET Prediction" Biomolecules 12, no. 8: 1093.
https://doi.org/10.3390/biom12081093
APA Style
Ramalingam, A., Mustafa, N., Chng, W. J., Medimagh, M., Sambandam, S., & Issaoui, N.
(2022). 3-Chloro-3-methyl-2,6-diarylpiperidin-4-ones as Anti-Cancer Agents: Synthesis, Biological Evaluation, Molecular Docking, and In Silico ADMET Prediction. Biomolecules, 12(8), 1093.
https://doi.org/10.3390/biom12081093
